SCHEMBL691856

SCHEMBL691856

O=C(O)NCc1ccc(C(=O)Cl)cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ POLB P06746 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ NAPRT Q6XQN6 1/20 0.41
▸ MAPK14 Q16539 1/20 0.40
▸ SCD O00767 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGDS O60760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18041383 0.77 FTO (0.42) NPC1RAB9APOLBLMNASMN1; SMN2
SCHEMBL22581561 0.77 ADORA2A (0.47) NPC1RAB9AL3MBTL1SMN1; SMN2KMT2A
SCHEMBL19555318 0.77 ESR1 (0.41) NPC1RAB9APOLBL3MBTL1LMNA
SCHEMBL8358807 0.77 NAPRT (0.42) NPC1RAB9AL3MBTL1SMN1; SMN2NAPRT
SCHEMBL2099046 0.76 KDM4E (0.47) NPC1RAB9ALMNASMN1; SMN2KDM4E
SCHEMBL15173772 0.76 ADORA2A (0.44) NPC1RAB9APOLBSMN1; SMN2KMT2A
SCHEMBL4121736 0.75 NAPRT (0.41) NPC1RAB9AL3MBTL1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL2772493 0.75 NAPRT (0.41) NPC1RAB9AL3MBTL1SMN1; SMN2NAPRT
SCHEMBL26093875 0.75 ALDH1A1 (0.39) NPC1RAB9APOLBL3MBTL1LMNA
SCHEMBL29546318 0.74 SIRT6 (0.44) NPC1RAB9APOLBL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421872-A1 THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2012-02-29 — — EP disclosed
WO-2010122091-A1 THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 — — WO disclosed
Send feedback